The meeting will give the public its first look at how Kennedy’s new ACIP panel will weigh the evidence for vaccines.
Gilead's PrEP drug lenacapavir, to marketed under the name Yeztugo, provides six months protection from HIV with a single shot.
Vinay Prasad is taking on top roles at the FDA, solidifying his position as a top advisor to Commissioner Marty Makary.
RFK Jr. and Trump allies push for psychedelics to treat PTSD and depression. FDA in position to greenlight MDMA and psilocybin for mental health treatment.
Supreme Court, in U.S. v. Skrmetti, upholds Tennessee ban on gender-affirming care for minors, sets precedent for more than states with similar laws.
The notion of faster drug reviews makes sense, but the "Commissioner’s National Priority Voucher" program also threatens to come at a cost.
Gene therapy holds promise for treating Duchenne muscular dystrophy. But after a second Elevidys death, the system must work better.
The Trump administration’s reckless slashing makes me worry we will be underprepared if a new virus or pathogen enters our blood supply.
STAT Video: With the future of NIH funding in jeopardy, Reed Jobs tells us how studying a lizard brought the world a blockbuster drug — Ozempic.
